Serwanga J - Search Results

1

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort.

Serwanga J, Kato L, Oluka GK, Ankunda V, Sembera J, Baine C, Kitabye I, Namuyanja A, Opio S, Katende JS, Ejou P; COVID-19 Immunoprofiling Team; Kaleebu P. Serwanga J, et al. Front Immunol. 2024 May 8;15:1384668. doi: 10.3389/fimmu.2024.1384668. eCollection 2024. Front Immunol. 2024. PMID: 38779677 Free PMC article.

2

HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans.

Kebba A, Kaleebu P, Serwanga J, Rowland S, Yirrell D, Downing R, Gilmour J, Imami N, Gotch F, Whitworth J. Kebba A, et al. Among authors: serwanga j. AIDS Res Hum Retroviruses. 2004 Jan;20(1):67-75. doi: 10.1089/088922204322749512. AIDS Res Hum Retroviruses. 2004. PMID: 15000700

3

Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans.

Serwanga J, Shafer LA, Pimego E, Auma B, Watera C, Rowland S, Yirrell D, Pala P, Grosskurth H, Whitworth J, Gotch F, Kaleebu P. Serwanga J, et al. PLoS One. 2009;4(1):e4188. doi: 10.1371/journal.pone.0004188. Epub 2009 Jan 14. PLoS One. 2009. PMID: 19142234 Free PMC article.

4

CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.

Serwanga J, Mugaba S, Betty A, Pimego E, Walker S, Munderi P, Gilks C, Gotch F, Grosskurth H, Kaleebu P. Serwanga J, et al. AIDS Res Treat. 2011;2011:875028. doi: 10.1155/2011/875028. Epub 2011 Jan 18. AIDS Res Treat. 2011. PMID: 21490785 Free PMC article.

5

Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.

Serwanga J, Mugaba S, Pimego E, Nanteza B, Lyagoba F, Nakubulwa S, Heath L, Nsubuga RN, Ndembi N, Gotch F, Kaleebu P. Serwanga J, et al. AIDS Res Hum Retroviruses. 2012 Apr;28(4):384-92. doi: 10.1089/AID.2011.0175. Epub 2011 Oct 17. AIDS Res Hum Retroviruses. 2012. PMID: 21867408 Free PMC article.

6

Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners.

Pala P, Serwanga J, Watera C, Ritchie AJ, Moodie Z, Wang M, Goonetilleke N, Birabwa E, Hughes P, Senkaali D, Nakiboneka R, Grosskurth H, Haynes B, McMichael A, Kaleebu P; Center for HIV/AIDS Vaccine Immunology. Pala P, et al. Among authors: serwanga j. J Virol. 2013 Aug;87(16):9053-63. doi: 10.1128/JVI.00721-13. Epub 2013 Jun 12. J Virol. 2013. PMID: 23760253 Free PMC article.

7

Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.

Serwanga J, Nakiboneka R, Mugaba S, Magambo B, Ndembi N, Gotch F, Kaleebu P. Serwanga J, et al. Vaccine. 2015 Mar 30;33(14):1664-72. doi: 10.1016/j.vaccine.2015.02.037. Epub 2015 Feb 26. Vaccine. 2015. PMID: 25728323 Free PMC article.

8

Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections.

Obuku AE, Bugembe DL, Musinguzi K, Watera C, Serwanga J, Ndembi N, Levin J, Kaleebu P, Pala P. Obuku AE, et al. Among authors: serwanga j. AIDS Res Hum Retroviruses. 2016 Mar;32(3):237-46. doi: 10.1089/AID.2015.0157. Epub 2015 Dec 9. AIDS Res Hum Retroviruses. 2016. PMID: 26548707

9

Association between serotonin transporter gene polymorphisms and increased suicidal risk among HIV positive patients in Uganda.

Kalungi A, Seedat S, Hemmings SMJ, van der Merwe L, Joloba ML, Nanteza A, Nakassujja N, Birabwa H, Serwanga J, Kaleebu P, Kinyanda E. Kalungi A, et al. Among authors: serwanga j. BMC Genet. 2017 Jul 25;18(1):71. doi: 10.1186/s12863-017-0538-y. BMC Genet. 2017. PMID: 28743254 Free PMC article.

10

HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.

Serwanga J, Ssemwanga D, Muganga M, Nakiboneka R, Nakubulwa S, Kiwuwa-Muyingo S, Morris L, Redd AD, Quinn TC, Kaleebu P; HIV Superinfection Study Group. Serwanga J, et al. Vaccine. 2018 Jan 25;36(4):578-586. doi: 10.1016/j.vaccine.2017.11.075. Epub 2017 Dec 20. Vaccine. 2018. PMID: 29274699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters